Skip to main content
Erschienen in: Clinical Research in Cardiology 7/2019

20.02.2019 | Original Paper

Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry

verfasst von: Charlotte Eitel, Hueseyin Ince, Johannes Brachmann, Karl-Heinz Kuck, Stephan Willems, Jin-Hong Gerds-Li, Juergen Tebbenjohanns, Gert Richardt, Matthias Hochadel, Jochen Senges, Roland R. Tilz

Erschienen in: Clinical Research in Cardiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Heart failure (HF) and atrial fibrillation (AF) often coexist, but data on the prognostic value of differing ablation strategies according to left ventricular ejection fraction (LVEF) are rare.

Methods and results

From January 2007 until January 2010, 728 patients with HF were enrolled in the multi-center German ablation registry prior to AF catheter ablation. Patients were divided into three groups according to LVEF: HF with preserved LVEF (≥ 50%, HFpEF, n = 333), mid-range LVEF (40–49%, HFmrEF, n = 207), and reduced LVEF (< 40%, HFrEF, n = 188). Ablation strategies differed significantly between the three groups with the majority of patients with HFpEF (83.4%) and HFmrEF (78.4%) undergoing circumferential pulmonary vein isolation vs. 48.9% of patients with HFrEF. The latter underwent ablation of the atrioventricular (AV) node in 47.3%. Major complications did not differ between the groups. Kaplan–Meier survival analysis demonstrated a significant mortality increase in patients with HFrEF (6.1% in HFrEF vs. 1.5% in HFmrEF vs. 1.9% in HFpEF, p = 0.009) that was limited to patients undergoing ablation of the AV node.

Conclusions

Catheter ablation strategies differ significantly in patients with HFpEF, HFmrEF, and HFrEF. In almost 50% of patients with HFrEF AV-node ablation was performed, going along with a significant increase in mortality rate. These results should raise efforts to further evaluate the prognostic effect of ablation strategies in HF patients.
Literatur
1.
Zurück zum Zitat Al HS, Qintar M, Hussein A et al (2015) Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. JACC Clin Electrophysiol 1:200–209CrossRef Al HS, Qintar M, Hussein A et al (2015) Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. JACC Clin Electrophysiol 1:200–209CrossRef
2.
Zurück zum Zitat Anselmino M, Matta M, D’ascenzo F et al (2014) Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 7:1011–1018CrossRefPubMed Anselmino M, Matta M, D’ascenzo F et al (2014) Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 7:1011–1018CrossRefPubMed
3.
Zurück zum Zitat Anter E, Jessup M, Callans DJ (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119:2516–2525CrossRefPubMed Anter E, Jessup M, Callans DJ (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119:2516–2525CrossRefPubMed
4.
Zurück zum Zitat Black-Maier E, Ren X, Steinberg BA et al (2018) Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm 5(5):651–657CrossRef Black-Maier E, Ren X, Steinberg BA et al (2018) Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm 5(5):651–657CrossRef
5.
Zurück zum Zitat Brachmann J, Lewalter T, Kuck KH et al (2017) Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J 38:1317–1326CrossRefPubMed Brachmann J, Lewalter T, Kuck KH et al (2017) Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J 38:1317–1326CrossRefPubMed
6.
Zurück zum Zitat Brignole M, Pokushalov E, Pentimalli F et al (2018) A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 39:3999–4008CrossRefPubMed Brignole M, Pokushalov E, Pentimalli F et al (2018) A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 39:3999–4008CrossRefPubMed
7.
Zurück zum Zitat Cappato R, Calkins H, Chen SA et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRefPubMed Cappato R, Calkins H, Chen SA et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRefPubMed
8.
Zurück zum Zitat Dagres N, Varounis C, Gaspar T et al (2011) Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail 17:964–970CrossRefPubMed Dagres N, Varounis C, Gaspar T et al (2011) Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail 17:964–970CrossRefPubMed
9.
Zurück zum Zitat Di BL, Mohanty P, Mohanty S et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133:1637–1644CrossRef Di BL, Mohanty P, Mohanty S et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133:1637–1644CrossRef
10.
Zurück zum Zitat Dong K, Shen WK, Powell BD et al (2010) Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Heart Rhythm 7:1240–1245CrossRefPubMed Dong K, Shen WK, Powell BD et al (2010) Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Heart Rhythm 7:1240–1245CrossRefPubMed
11.
Zurück zum Zitat Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology/american heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European heart rhythm association and the heart rhythm society. Circulation 114:e257–e354CrossRef Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology/american heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European heart rhythm association and the heart rhythm society. Circulation 114:e257–e354CrossRef
12.
Zurück zum Zitat Jobs A, Schwind J, Katalinic A et al (2019) Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction. Clin Res Cardiol 108(1):74–82CrossRefPubMed Jobs A, Schwind J, Katalinic A et al (2019) Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction. Clin Res Cardiol 108(1):74–82CrossRefPubMed
13.
Zurück zum Zitat Kareti KR, Chiong JR, Hsu SS et al (2005) Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail 11:164–172CrossRefPubMed Kareti KR, Chiong JR, Hsu SS et al (2005) Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail 11:164–172CrossRefPubMed
14.
Zurück zum Zitat Khan MN, Jais P, Cummings J et al (2008) Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 359:1778–1785CrossRefPubMed Khan MN, Jais P, Cummings J et al (2008) Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 359:1778–1785CrossRefPubMed
15.
Zurück zum Zitat Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRef Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRef
16.
Zurück zum Zitat Li D, Fareh S, Leung TK et al (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87–95CrossRefPubMed Li D, Fareh S, Leung TK et al (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87–95CrossRefPubMed
17.
Zurück zum Zitat Machino-Ohtsuka T, Seo Y, Ishizu T et al (2013) Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol 62:1857–1865CrossRefPubMed Machino-Ohtsuka T, Seo Y, Ishizu T et al (2013) Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol 62:1857–1865CrossRefPubMed
18.
Zurück zum Zitat Marrouche NF, Brachmann J, Andresen D et al (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427CrossRefPubMed Marrouche NF, Brachmann J, Andresen D et al (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427CrossRefPubMed
19.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed
20.
Zurück zum Zitat Pozzoli M, Cioffi G, Traversi E et al (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197–204CrossRefPubMed Pozzoli M, Cioffi G, Traversi E et al (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197–204CrossRefPubMed
21.
Zurück zum Zitat Prabhu S, Taylor AJ, Costello BT et al (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 70:1949–1961CrossRefPubMed Prabhu S, Taylor AJ, Costello BT et al (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 70:1949–1961CrossRefPubMed
Metadaten
Titel
Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry
verfasst von
Charlotte Eitel
Hueseyin Ince
Johannes Brachmann
Karl-Heinz Kuck
Stephan Willems
Jin-Hong Gerds-Li
Juergen Tebbenjohanns
Gert Richardt
Matthias Hochadel
Jochen Senges
Roland R. Tilz
Publikationsdatum
20.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 7/2019
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-019-01411-3

Weitere Artikel der Ausgabe 7/2019

Clinical Research in Cardiology 7/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.